首页> 外文期刊>Peptides: An International Journal >Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia.
【24h】

Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia.

机译:慢性心力衰竭患者尤其是恶病质患者的循环生长素释放肽和肥胖抑制素紊乱。

获取原文
获取原文并翻译 | 示例
       

摘要

Plasma ghrelin was elevated in chronic heart failure (CHF) patients with cachexia. Obestatin, a sibling of ghrelin, opposes several actions of ghrelin. We, therefore, investigated plasma obestatin and ghrelin levels in patients with CHF. Total plasma ghrelin and obestatin levels were measured in 65 patients with CHF (22 with cardiac cachexia) and 15 controls. Ghrelin levels were significantly higher in patients with cachexia (1237.8+/-47.9 pg/ml) than those without cachexia (P=0.041) and controls (P<0.01). Obestatin levels correlated positively with ghrelin levels, and obestatin levels were significantly increased in patients with cachexia (282.3+/-13.0 pg/ml) than patients without cachexia and controls (both P<0.01). However, the ghrelin to obestatin ratios (4.5+/-0.2) were significantly lower in CHF patients with cachexia than controls (P<0.01). Ghrelin and ratio of ghrelin to obestatin were independent predictors of the development of cardiac cachexia. No association was found between ghrelin, obestatin and New York Heart Association functional class, brain natriuretic peptide. There was disturbance of circulating ghrelin and obestatin in the CHF patients especially those with cachexia, which may have a role in the pathogenesis of cardiac cachexia in CHF.
机译:患有恶病质的慢性心力衰竭(CHF)患者血浆生长素释放肽升高。 Obestatin是Ghrelin的兄弟姐妹,反对Ghrelin的几种作用。因此,我们调查了CHF患者血浆中的血浆雌激素和生长素释放肽水平。在65例CHF患者(22例患有心脏恶病质)和15例对照中测量了总血浆生长素释放肽和Obestatin水平。恶病质患者中的Ghrelin水平(1237.8 +/- 47.9 pg / ml)显着高于无恶病质患者(P = 0.041)和对照组(P <0.01)。肥胖抑制素的水平与生长素释放肽水平呈正相关,患有恶病质的患者(282.3 +/- 13.0 pg / ml)的肥胖素水平明显高于无恶病质和对照组的患者(两者均P <0.01)。然而,患有恶病质的CHF患者的生长素释放肽与肥胖抑制素的比率(4.5 +/- 0.2)显着低于对照组(P <0.01)。 Ghrelin和Ghrelin与Obestatin的比率是心脏恶病质发展的独立预测因子。 ghrelin,肥胖抑制素与纽约心脏协会功能类别脑利钠肽之间未发现关联。 CHF患者,尤其是恶病质患者,其循环生长素释放肽和肥胖抑制素存在紊乱,可能与CHF心脏恶病质的发病机制有关。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号